W10-1911 |
previous work on BNER for disease
|
mention recognition
|
. Then , Section 3 describes
|
W10-1911 |
not enough work done on disease
|
mention recognition
|
. Difficulty of obtaining adequate
|
W07-1000 |
, the number of papers on gene
|
mention recognition
|
was quite small . We did see
|
P12-1089 |
results evaluated on the named
|
mention recognition
|
task are superior overall , giving
|
W10-1911 |
specifically tailored for disease
|
mention recognition
|
. The system1 outperforms other
|
S10-1001 |
might be a direct effect of the
|
mention recognition
|
task . Mention recognition in
|
W10-1902 |
performing systems in the Gene
|
Mention Recognition
|
task of BioCreAtIvE II ( Smith
|
W10-1911 |
mostly focused on gene/protein
|
mention recognition
|
. Machine learning ( ML ) based
|
W10-1902 |
used in the BioCreAtIvE II Gene
|
Mention Recognition
|
task in 2006 . It was built from
|
W10-1911 |
based approaches for gene/protein
|
mention recognition
|
have already achieved a sufficient
|
S15-2067 |
coupling sequence la - belling for
|
mention recognition
|
with an STS measure for concept
|
W10-1911 |
specifically for benchmarking of disease
|
mention recognition
|
systems . An improved version
|
S10-1001 |
the mention recognition task .
|
Mention recognition
|
in the regular setting falls
|
E14-1052 |
ACE 2005 , but it seems that its
|
mention recognition
|
is not designed for ACE 2005
|
W10-1911 |
BNER is focused on gene/protein
|
mention recognition
|
. State-of-the-art BNER systems
|
W10-1911 |
feature set tailored for disease
|
mention recognition
|
and outperforms the state-ofthe-art
|
W10-1902 |
and Pereira , 2005 ) . The Gene
|
Mention Recognition
|
task was included in both BioCreAtIvE
|
W10-1911 |
the well studied gene/protein
|
mention recognition
|
task is not necessarily equally
|
W10-1911 |
scope rules . <title> Disease
|
Mention Recognition
|
with Specific Features </title>
|
W10-1911 |
of the art on ML based disease
|
mention recognition
|
in biomedical literature ( Leaman
|